نتائج البحث - Meng‐Yao Lu

  • يعرض 1 - 9 نتائج من 9
تنقيح النتائج
  1. 1
    Severe Bacterial Infection in Transfusion-Dependent Patients with Thalassemia Major

    Severe Bacterial Infection in Transfusion-Dependent Patients with Thalassemia Major حسب Shu Wang, Kai‐Hsin Lin, Jimmy P.S. Chern, Meng‐Yao Lu, Shiann‐Tarng Jou, Dong‐Tsamn Lin, Kuo‐Sin Lin

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial

    Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial حسب Manuel Carção, Marek Žák, F. Abdul Karim, Hideji Hanabusa, Susan Kearney, Meng‐Yao Lu, Paula Persson, Savita Rangarajan, Elena Santagostino

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients

    Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients حسب Jimmy P.S. Chern, Kai‐Hsin Lin, Meng‐Yao Lu, Dong‐Tsam Lin, Kuo‐Sin Lin, Jong‐Dar Chen, Cheng-Chung Fu

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma

    Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma حسب Jia‐Feng Wu, Hsiu‐Hao Chang, Meng‐Yao Lu, Shiann‐Tarng Jou, Kai‐Chi Chang, Yen‐Hsuan Ni, Mei‐Hwei Chang

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety

    Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety حسب Chiao-Yu Cheng, Meng‐Yao Lu, Hsiu‐Hao Chang, Yung‐Li Yang, Chia-Chen Wu, Dong‐Tsamn Lin, Kai‐Hsin Lin, Shu‐Wei Chou, Shiann‐Tarng Jou

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Newborn Screening for Severe Combined Immunodeficiency in Taiwan

    Newborn Screening for Severe Combined Immunodeficiency in Taiwan حسب Yin‐Hsiu Chien, Hsin‐Hui Yu, Ni‐Chung Lee, Hui-Chen Ho, Shu-Min Kao, Meng‐Yao Lu, Tang‐Her Jaing, Wen-I Lee, Kuei-Wen Chang, Chi-Chang Shieh, Jiann-Shiuh Chen, Shu‐Chuan Chiang, Chen-Chen Liu, Wuh‐Liang Hwu

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY

    S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY حسب Franco Locatelli, Bülent Antmen, Hyoung Jin Kang, Katsuyoshi Koh, Yoshiyuki Takahashi, Alphan Küpesiz, Maria Gabriela Matos, Donna A. Wall, Sunil Bhat, Ho Joon Im, Tayfun Güngör, Meng‐Yao Lu, Tommaso Stefanelli, Christine Rosko, Annie St. Pierre, K. Burock, Cristina Díaz de Heredia

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Characterization of Neuroblastic Tumors Using <sup>18</sup>F-FDOPA PET

    Characterization of Neuroblastic Tumors Using <sup>18</sup>F-FDOPA PET حسب Meng‐Yao Lu, Yen-Lin Liu, Hsiu‐Hao Chang, Shiann‐Tarng Jou, Yung‐Li Yang, Kai‐Hsin Lin, Dong‐Tsamn Lin, Ya‐Ling Lee, Hsinyu Lee, Pei‐Yi Wu, Tsai-Yueh Luo, Lie-Hang Shen, Shiu‐Feng Huang, Yung-Feng Liao, Wen‐Ming Hsu, Kai‐Yuan Tzen

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

    A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia حسب Maria Domenica Cappellini, Vip Viprakasit, Alì Taher, Pencho Georgiev, Kevin H.M. Kuo, Thomas D. Coates, Ersi Voskaridou, Hong-Keng Liew, Idit Pazgal-Kobrowski, Gian Luca Forni, Silverio Perrotta, Abderrahim Khélif, Ashutosh Lal, Antonis Kattamis, Efthymia Vlachaki, Raffaella Origa, Yeşim Aydınok, Mohamed Béjaoui, P. Joy Ho, Lee-Ping Chew, Ping Chong Bee, Soo-min Lim, Meng‐Yao Lu, Adisak Tantiworawit, Penka Ganeva, Liana Gercheva, Farrukh Shah, Ellis J. Neufeld, Alexis A. Thompson, Abderrahmane Laadem, Jeevan K. Shetty, Jun Zou, Jennie Zhang, Dimana Miteva, Tatiana Zinger, Peter G. Linde, Matthew L. Sherman, Olivier Hermine, John B. Porter, Antonio Piga

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: